SL
TAK icon

Savior LLC’s Takeda Pharmaceutical TAK Stock Holding History

Savior LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-448
Closed -$8K – 700
2021
Q2 		$8K Sell
448
-305
-41% -$5.19K 0.01% 463
2021
Q1 		$14K Hold
753
– – 0.01% 353
2020
Q4 		$14K Buy
753
+305
+68% +$5.35K 0.01% 346
2020
Q3 		$8K Hold
448
– – 0.01% 426
2020
Q2 		$8K Hold
448
– – 0.01% 381
2020
Q1 		$7K Hold
448
– – 0.01% 387
2019
Q4 		$9K Buy
+448
New +$8.57K 0.01% 454

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Savior LLC's TAK Position: Q3 2021 in Review

Savior LLC sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 448 shares — an estimated $8K sold.

Savior LLC first reported a position in TAK in Q4 2019 and held it in 7 quarters. The position peaked at $14K in Q1 2021. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

  • Savior LLC reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 448 Takeda Pharmaceutical shares in Q3 2021, an estimated $8K.
  • Savior LLC first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Takeda Pharmaceutical position peaked at $14K in Q1 2021.
  • 292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.